192 related articles for article (PubMed ID: 38151631)
21. EpCAM is a putative stem marker in retinoblastoma and an effective target for T-cell-mediated immunotherapy.
Mitra M; Kandalam M; Harilal A; Verma RS; Krishnan UM; Swaminathan S; Krishnakumar S
Mol Vis; 2012; 18():290-308. PubMed ID: 22328825
[TBL] [Abstract][Full Text] [Related]
22. 3D model for CAR-mediated cytotoxicity using patient-derived colorectal cancer organoids.
Schnalzger TE; de Groot MH; Zhang C; Mosa MH; Michels BE; Röder J; Darvishi T; Wels WS; Farin HF
EMBO J; 2019 Jun; 38(12):. PubMed ID: 31036555
[TBL] [Abstract][Full Text] [Related]
23. Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM.
Deng Z; Wu Y; Ma W; Zhang S; Zhang YQ
BMC Immunol; 2015 Jan; 16(1):1. PubMed ID: 25636521
[TBL] [Abstract][Full Text] [Related]
24. Bispecific Antibodies Enable Synthetic Agonistic Receptor-Transduced T Cells for Tumor Immunotherapy.
Karches CH; Benmebarek MR; Schmidbauer ML; Kurzay M; Klaus R; Geiger M; Rataj F; Cadilha BL; Lesch S; Heise C; Murr R; Vom Berg J; Jastroch M; Lamp D; Ding J; Duewell P; Niederfellner G; Sustmann C; Endres S; Klein C; Kobold S
Clin Cancer Res; 2019 Oct; 25(19):5890-5900. PubMed ID: 31285373
[TBL] [Abstract][Full Text] [Related]
25. CD24+CD44+CD54+EpCAM+ gastric cancer stem cells predict tumor progression and metastasis: clinical and experimental evidence.
Gómez-Gallegos AA; Ramírez-Vidal L; Becerril-Rico J; Pérez-Islas E; Hernandez-Peralta ZJ; Toledo-Guzmán ME; García-Carrancá A; Langley E; Hernández-Guerrero A; López-Casillas F; Herrera-Goepfert R; Oñate-Ocaña LF; Ortiz-Sánchez E
Stem Cell Res Ther; 2023 Feb; 14(1):16. PubMed ID: 36737794
[TBL] [Abstract][Full Text] [Related]
26. TLR4, IgA and EpCAM Expression in Colorectal Cancer and Their Possible Association with Microbiota as a Pathogenic Factor; An Immunohistochemical and Genetic Study.
Hafez FS; Shakweer MM; Sabry D; Tawfik AM; El-Beah SM; Elsheshtawy NM; Shash LS; Salama DEA; Gaballah A
Asian Pac J Cancer Prev; 2024 Feb; 25(2):627-636. PubMed ID: 38415550
[TBL] [Abstract][Full Text] [Related]
27. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1.
Park DJ; Sung PS; Kim JH; Lee GW; Jang JW; Jung ES; Bae SH; Choi JY; Yoon SK
J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32221015
[TBL] [Abstract][Full Text] [Related]
28. Epithelial cell adhesion molecule fragments and signaling in primary human liver cells.
Gerlach JC; Foka HG; Thompson RL; Gridelli B; Schmelzer E
J Cell Physiol; 2018 Jun; 233(6):4841-4851. PubMed ID: 29150960
[TBL] [Abstract][Full Text] [Related]
29. Effects of immuno-related gene polymorphisms on a bispecific antibody targeting colorectal cancer cell.
Zhang CM; Yu LY; Lv JF; Gong L; Zhou HH; Chen XP; Fan L
Per Med; 2018 May; 15(3):167-179. PubMed ID: 29790821
[TBL] [Abstract][Full Text] [Related]
30. Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia.
Willms A; Müller C; Julich H; Klein N; Schwab R; Güsgen C; Richardsen I; Schaaf S; Krawczyk M; Krawczyk M; Lammert F; Schuppan D; Lukacs-Kornek V; Kornek M
Oncotarget; 2016 May; 7(21):30867-75. PubMed ID: 27127176
[TBL] [Abstract][Full Text] [Related]
31. Depicting adoptive immunotherapy for prostate cancer in an animal model with magnetic resonance imaging.
Meier R; Golovko D; Tavri S; Henning TD; Knopp C; Piontek G; Rudelius M; Heinrich P; Wels WS; Daldrup-Link H
Magn Reson Med; 2011 Mar; 65(3):756-63. PubMed ID: 20928869
[TBL] [Abstract][Full Text] [Related]
32. A high-content screen for small-molecule regulators of epithelial cell-adhesion molecule (EpCAM) cleavage yields a robust inhibitor.
Tretter JY; Schorpp K; Luxenburger E; Trambauer J; Steiner H; Hadian K; Gires O; Niessing D
J Biol Chem; 2018 Jun; 293(23):8994-9005. PubMed ID: 29700109
[TBL] [Abstract][Full Text] [Related]
33.
Xu T; Karschnia P; Cadilha BL; Dede S; Lorenz M; Seewaldt N; Nikolaishvili E; Müller K; Blobner J; Teske N; Herold JJ; Rejeski K; Langer S; Obeck H; Lorenzini T; Mulazzani M; Zhang W; Ishikawa-Ankerhold H; Buchholz VR; Subklewe M; Thon N; Straube A; Tonn JC; Kobold S; von Baumgarten L
Oncoimmunology; 2023; 12(1):2163781. PubMed ID: 36687005
[TBL] [Abstract][Full Text] [Related]
34. Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies.
Hägerbrand K; Varas L; Deronic A; Nyesiga B; Sundstedt A; Ljung L; Sakellariou C; Werchau D; Thagesson M; Gomez Jimenez D; Greiff L; Celander M; Smedenfors K; Rosén A; Bölükbas D; Carlsson F; Levin M; Säll A; von Schantz L; Lindstedt M; Ellmark P
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36323431
[TBL] [Abstract][Full Text] [Related]
35. EpCAM Aptamer-Functionalized Cationic Liposome-Based Nanoparticles Loaded with miR-139-5p for Targeted Therapy in Colorectal Cancer.
Zhao Y; Xu J; Le VM; Gong Q; Li S; Gao F; Ni L; Liu J; Liang X
Mol Pharm; 2019 Nov; 16(11):4696-4710. PubMed ID: 31589818
[TBL] [Abstract][Full Text] [Related]
36. Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro.
Ferrari F; Bellone S; Black J; Schwab CL; Lopez S; Cocco E; Bonazzoli E; Predolini F; Menderes G; Litkouhi B; Ratner E; Silasi DA; Azodi M; Schwartz PE; Santin AD
J Exp Clin Cancer Res; 2015 Oct; 34():123. PubMed ID: 26474755
[TBL] [Abstract][Full Text] [Related]
37. Bispecific antibody-mediated redirection of NKG2D-CAR natural killer cells facilitates dual targeting and enhances antitumor activity.
Zhang C; Röder J; Scherer A; Bodden M; Pfeifer Serrahima J; Bhatti A; Waldmann A; Müller N; Oberoi P; Wels WS
J Immunother Cancer; 2021 Oct; 9(10):. PubMed ID: 34599028
[TBL] [Abstract][Full Text] [Related]
38. Integrated bio-affinity nano-platform into a microfluidic immunosensor based on monoclonal bispecific trifunctional antibodies for the electrochemical determination of epithelial cancer biomarker.
Bravo K; Ortega FG; Messina GA; Sanz MI; Fernández-Baldo MA; Raba J
Clin Chim Acta; 2017 Jan; 464():64-71. PubMed ID: 27836687
[TBL] [Abstract][Full Text] [Related]
39. Clinical effects of a chimeric anti-EpCAM monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor in patients with metastatic colorectal carcinoma.
Liljefors M; Nilsson B; Fagerberg J; Ragnhammar P; Mellstedt H; Frödin JE
Int J Oncol; 2005 Jun; 26(6):1581-9. PubMed ID: 15870873
[TBL] [Abstract][Full Text] [Related]
40. Tetraspecific scFv construct provides NK cell mediated ADCC and self-sustaining stimuli via insertion of IL-15 as a cross-linker.
Schmohl JU; Felices M; Todhunter D; Taras E; Miller JS; Vallera DA
Oncotarget; 2016 Nov; 7(45):73830-73844. PubMed ID: 27650544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
